Tag: retatrutide
-
Retatrutide Explained: Mechanism, Clinical Research and Current Status
Retatrutide is an investigational GIP, GLP-1 and glucagon receptor agonist. What the trials show, what remains unknown, and why it is not an approved medicine.
NovaMeds
Retatrutide is an investigational GIP, GLP-1 and glucagon receptor agonist. What the trials show, what remains unknown, and why it is not an approved medicine.